Skip to main content


Fig. 1 | BMC Cancer

Fig. 1

From: IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer

Fig. 1

Characterization of the expression of genes encoding proteins involved in the IGF pathway points out dysregulation of IGF pathway in bladder tumors. Levels of mRNA for IGF receptors, ligands, and binding proteins (Log2 scale), according to tumor stage, for the FBLAD-Exon dataset. *: p value = 0.01 to 0.05 **: p value = 0.001 to 0.01 ***: p value ≤0.001

Back to article page